AnCan’s Art Director and MS Moderator, Hannah Garrison, Honored!

AnCan’s Art Director and MS Moderator, Hannah Garrison, Honored!

AnCan’s Art Director and MS Moderator, Hannah Garrison, Honored!

The Multiple Sclerosis Association of America has recently recognized one of AnCan’s favorite moderators, Hannah Garrison as their Annual 2022 Benefit Honoree!

AnCan LOVES Hannah ….. she is a longtime moderator of our MS Groups AND leads the AnCan Art Program that teaches everyone that no matter your abilities, art is not out of reach. Check our AnCan Art Gallery to see the work Hannah has helped our participants create. Btw, that program will be back in 2022 with 4 sessions before year end – and we’ll be providing FREE art supplies!

Every year, MSAA names one corporate honoree, and one from the MS community. This year
Hannah was recognized as the MS Community Member of the Year,. She has been working with the
MSAA to lead and develop their “Improving Lives Through Art” Paint-Along series throughout 2021 – a program that we beta-tested here at AnCan.

This is amongst MSAA’s newest set of virtual fundraising events in which participants paint a predetermined subject together in a virtual “classroom”, instructed by  Hannah. Hannah sets the subject, MSAA sends the supplies off to participants’ homes, and everyone who joins in has a chance to create a special piece of artwork with family or friends together with everyone in the virtual room. The program is a huge success, and continues to support the MSAA’s mission to fund programs specifically for the MS community.

Hannah is adamant that the visual arts were a stepping stone in her recovery from the grueling effects of multiple sclerosis. One day she decided she’d had enough, and began working through her mental struggles, cognitive struggles, and physical struggles via the process of making art. Now Hannah Garrison uses art as a safe space to explore her struggles and to sit with them – never to judge or belittle any result that takes place … or for that matter anything that arises along the way!

Hannah has AMAZED some of our AnCan particpants who have told us they never thought they had this creative talent within them.

You can read about Hannah here, and learn more about the MSAA Benefit which took place on May 5 th in-person and May 12th virtually, here.

Watch out for our four (4) 2022 Art with Hannah sessions, coming soon. You can reach Hannah Garrison at hannah@ancan.org if you want to be sure to receive an invite to AnCan’s classes – they are open to all.

Time Toxicity raises thoughts …

Time Toxicity raises thoughts …

Time Toxicity raises thoughts …

Some may have read the excellent ediorial written by Moderator Ben Nathanson in a recent High Risk/Recurrent/Advanced Prostate Cancer Reminder. Ben explains ‘time toxicity’ … a concept that effects many living with serious disease.  If you missed his musings, here they are again:

Treatment that gives us time to live demands time in return. It drags with it scans, blood work, drives to the hospital, doctors running late, computers down, battles with insurance. Part of our gained lifetime is lost in dead time.
Toxicity is always in the cancer mix. Financial toxicity has become part of the conversation alongside physiological toxicity, and time toxicity — time lost in an effort to gain time — is joining it.
In a thoughtful 2018 essay, physician Karen Daily notes “Much of our patients’ time investments remain invisible to clinicians.”  This year, in ASCO’s lead journal, three physicians have taken up the challenge, proposing that clinical trials, when reporting overall survival, distinguish between “Days with Physical Health Care System Contact” and days the patients actually own — “Home Days.” This a new idea only in cancer, say the authors — cardiology and other fields already make these kinds of measurements.
When medicine’s best offer is a handful of months, we face difficult choices. Time toxicity casts a shadow over both survival time and quality of life. As we try to balance days added against side effects, it would be good to know how much of the time we’re gaining will be ours to spend. 

Reading Ben’s thoughts prompted one of our regular participants to write a reply to us both that touched me to the core. I asked if we could reprint that too, and was graciously given permission on condition of anonymity. Here it is!

Ben, thanks for the article on “time toxicity” in the (recent) meeting announcement.  It identifies an important consideration for all to think about in the fight vs. cancer and from my personal experience an impact that changes over time.  Your write-up got me to thinking and pushed me to a holistic realization that this is basically an investment decision with expected returns.

For the prostate component of my cancer fight (now 17 years and counting), I did not think about the time investment in the first 14 years that I (and family members) were making to “do battle” (eg lab work, appointments with doctors, scans, treatments, family meetings, insurance challenges and personal downtime / reduced effectiveness in work due to treatment, etc.),  It was a “no-brainer” decision and I never considered the tradeoff as the benefits for the opportunity to “continue to live life” due to treatments as my “life” returns were overwhelmingly positive vs.the “investment” required to do battle.  
Having retired three years ago and simultaneously entering a new phase of my cancer fight I am aware of the increased time I (and family members) now spend on cancer treatment yet obtaining reduced time for life (and quality of life).  I’m now spending significantly more time at Doctors appointments, treatments and longer periods of time post treatment feeling the physical effects of treatment and have begun to recognize I’m going to hit a point where this equation gets out of balance….and I’m not equipped with a decision model to manage that occurrence.   Given my personal nature is to grind on stuff (I can make it work, give me time and let me try!) — I’m likely to blow right past the point of equilibrium where time toxicity and balance of life toxicity begin to get out of hand.  For much of the first 14 years of  my cancer fight I practiced a very large (and for me, healthy) dose of self-denial that I was dealing with prostate cancer.  I was able to keep the cancer part of my life cordoned off, did not have significant  residual time spent thinking / worrying / etc. about the disease and lived life to the max both personally and professionally.  Now, in the last three years I am finding growing quantities of “thinking time” consumed by the disease and also sucking family members…. wife and children….deeper into the cancer battle as discussions / time encroach on them as well increasing the cost of investment (time) in the battle vs. cancer.
Prostate cancer is my second cancer fight,  Ten years prior to the prostate cancer diagnosis I was diagnosed with a rare leukemia (rare as it was diagnosed in a limited number of folks (~2,000 / per year in the United States) and was usually fatal shortly after diagnosis as there were no lasting treatments until about 4 years prior to my diagnosis.  As a freak outcome of scientific research a drug treatment was developed; the drug was intended for another cancer that had a much larger annual incidence of new cases; the drug was not effective on the targeted cancer but it was very effective on the rare leukemia.   And at the time the treatment protocol was 7 days of continuous drip via a small pump one wore around the waist as an outpatient; minimal side effects; and if the first treatment didn’t work a second round was almost guaranteed to work.  Talk about lucky!  There was no way research funds would have been spent on this cure except by accident — which was exactly the case.  The time toxicity for me in my first cancer battle was non-existent and I believe has indirectly helped me in the prostate cancer fight by giving me a dose of optimism and coping skills.
I think the topics raised by both of you….including Rick’s statement on treatment longevity results are important for the group to consider. These are relevant points of management in the cancer battle that I haven’t seen addressed by my oncologists (except one) nor psychologists and psychiatrists that I’ve also used in my treatment. 
Editor’s Comment: In the original Reminder, I responded to Ben’s comments by adding one of my own. I pointed out that frequently Overall Survival benefits were shorter than might be expected because trials are often run on patients at a very late stage of their disease. This caveat should be considerd when we see the FDA reporting short life extension, sometimes as few as 2 or 3 months, for newly approved drugs.(rd)
Breaking News: AnCan Partners with the Modern Medicaid Alliance

Breaking News: AnCan Partners with the Modern Medicaid Alliance

AnCan is proud to announce that we recently joined the Modern Medicaid Alliance, a partnership
between Americans who value Medicaid and leading advocacy organizations. We look forward to
working with the Alliance to educate policymakers and the public about the benefits and value of
Medicaid.

As part of our partnership with the Modern Medicaid Alliance, we will be highlighting the diverse
populations that depend on Medicaid for their health and financial security. Medicaid covers about
1 in 5 Americans, including millions of children, older adults, people with disabilities, and 2million

veterans. Medicaid provides an essential safety net for when Americans need it, providing high-
quality, cost-effective care to more than 73 million people nationwide.

We join the Modern Medicaid Alliance at a critical time. While policymakers debate changes to
Medicaid, the program is enjoying widespread support from Americans. In fact, recent polling
found that 86% of Americans want a strong, sustainable Medicaid program – and fewer than 20%
of Americans support cutting Medicaid funding.

AnCan is particularly interested in furthering Medicaid expansion in all States in order to
promote health equity. Indeed, providing mental health services to veterans and to all those
enduring chronic conditions is an urgent need.

 

See the full release by clicking here.

Hi-Risk/Recurrent/Advanced PCa Video Chat, Mar 21, 2022

Hi-Risk/Recurrent/Advanced PCa Video Chat, Mar 21, 2022

Hi-Risk/Recurrent/Advanced PCa Video Chat, Mar 21, 2022

 

Apologies to all this week as the Reminder did not go to the full distribution list. My error whilst on the road! Nonetheless, you can catch up now … (rd)

Next meeting will be on Apr 4, 2022

All AnCan’s groups are free and drop-in – join us in person sometime!  You can find out more about this and our other 10 monthly prostate cancer groups at https://ancan.org/prostate-cancer/   Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Editor’s Pick: Peter K says “We have to strategize our own treatment!” And how can we fail to mention Jerry Dean’s incredible courage and attitude?!? (rd)

Topics Discussed

Prostate Cancer brain mets and Tx; new de novo Mx man discusses his Tx path; pembro will bve next Tx for MSI-H gent; what’s next – darolutamide, Provenge??; we have to strategize our own treatment; metformin; Orgovyx; super-broccoli; AUA Summit; Lu177 PSMA in Phoenix

Chat Log

Peter Kafka – Maui (to Everyone): 5:38 PM: Was the brain cancer Prostate cancer? I might have missed that.

William Franklin (to Everyone): 5:41 PM: He saiid it was unrelated.

Peter Kafka – Maui (to Everyone): 5:53 PM: IMUDX swab test provides info about whether Keytruda will be tolerated.

Pat Martin (to Everyone): 5:57 PM: Thanks to all.

Peter Kafka – Maui (to Everyone): 6:09 PM: What about Provenge at this point?

AnCan – rick (to Everyone): 6:19 PM: Metformin

Julian Morales-Houston (to Everyone): 6:41 PM: https://www.pcf.org/blog/broccoli-and-prostate-cancer-whats-the-connection/

Julian Morales-Houston (to Everyone): 6:44 PM: I eat roasted brocolli along with brussel sprouts on a regular basis.

George Rovder Arlington VA (to Everyone): 6:45 PM: Thanks Rick.

Frank Fabish – Ohio (to Everyone): 6:47 PM: Got to go guys.

Len Sierra (to Everyone): 6:48 PM: That PCF site said eating broccoli had the anti-inflammatory effect of one Advil. So, take an Advil and call me in the morning.

Jeff Marchi (to Everyone): 6:48 PM: can’t take advil, on blood thinners

AnCan Recognized by GU ASCO22 For Peer Led Support Groups

AnCan Recognized by GU ASCO22 For Peer Led Support Groups

AnCan Recognized by GU ASCO22 For Peer Led Support Groups

 

AnCan Foundation is honored to announce its Abstract #58: Evaluating The Contribution of Virtual Peer-Led Support to Comprehensive Prostate Cancer (PCa) Care: The AnCan Experience together with a virtual poster has been selected for the ASCO Genitourinary Cancers Symposium, Feb 17-19, 2022 in San Francisco. DOI: 10.1200/JCO.2022.40.6_suppl.058

AnCan’s founder, Rick Davis, innovated virtual peer-led support groups back in 2010. He recognized the potential of peer advice as the best information a patient could find. AnCan’s 2021 research confirms what Rick knew intuitively.

Neuroscientist Herb Geller PhD, the abstract’s lead author, highlighted the following key research findings, 

“Our research indicates that peer-led groups don’t just improve quality of life around the things we can control like diet, exercise and stress. Eighty percent of our participants feel the groups make them better advocates for themselves, and well over 60% take information gleaned back to their healthcare teams.”

While this poster is featured in the Advanced Prostate Cancer track on Feb 17, AnCan is proud of its work to establish the stature of the low risk Active Surveillance (AS) protocol and includes its AS findings. 

Co-author and nationally recognized AS Advocate, Howard Wolinsky, said:

“Sixty eight percent of our AS participants told us the Groups made them better advocates and 27% reported lower levels of anxiety – that’s a major difference. Active surveillance is the Rodney Dangerfield of prostate cancer – including our study at GU ASCO recognizes AS patients”

Rick Davis, founder of AnCan and a prostate cancer survivor, says the research demonstrates the power of patient communities on outcomes:

“I realized the power of peer-led support groups from my own treatment. Bringing them to a virtual platform 10 years before anyone had ever heard of COVID-19 and Zoom meetings, made peer support available to those compromised by geographical, physical and social issues. Recognition by GU ASCO is a big step in legitimizing AnCan’s work for all peer-led support.”

 

View full press release here,

View the poster here.

For information on our peer-led video chat VIRTUAL SUPPORT GROUPS, click here.

To SIGN UP for any of our groups, visit our Contact Us page.